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Shuttling mammalian splicing factors <p>A genome wide identification of mRNAs that were associated with the splicing factor subunit U2AF65 suggests that U2AF65 associates  with specific subsets of spliced mRNAs and may be involved in novel cellular functions in addition to splicing.</p>
Abstract
Background:  Pre-mRNA splicing is an essential step in gene expression that occurs co-
transcriptionally in the cell nucleus, involving a large number of RNA binding protein splicing
factors, in addition to core spliceosome components. Several of these proteins are required for the
recognition of intronic sequence elements, transiently associating with the primary transcript
during splicing. Some protein splicing factors, such as the U2 small nuclear RNP auxiliary factor
(U2AF), are known to be exported to the cytoplasm, despite being implicated solely in nuclear
functions. This observation raises the question of whether U2AF associates with mature mRNA-
ribonucleoprotein particles in transit to the cytoplasm, participating in additional cellular functions.
Results: Here we report the identification of RNAs immunoprecipitated by a monoclonal antibody
specific for the U2AF 65 kDa subunit (U2AF65) and demonstrate its association with spliced
mRNAs. For comparison, we analyzed mRNAs associated with the polypyrimidine tract binding
protein (PTB), a splicing factor that also binds to intronic pyrimidine-rich sequences but additionally
participates in mRNA localization, stability, and translation. Our results show that 10% of cellular
mRNAs expressed in HeLa cells associate differentially with U2AF65 and PTB. Among U2AF65-
associated mRNAs there is a predominance of transcription factors and cell cycle regulators,
whereas PTB-associated transcripts are enriched in mRNA species that encode proteins implicated
in intracellular transport, vesicle trafficking, and apoptosis.
Conclusion: Our results show that U2AF65 associates with specific subsets of spliced mRNAs,
strongly suggesting that it is involved in novel cellular functions in addition to splicing.
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Background
Recent work emphasizes how post-transcriptional control of
gene expression is more pervasive than was previously
thought. It is now clear that every step of mRNA metabolism
can be subject to dynamic regulation events that act in a tran-
script-specific manner [1], and genome-wide approaches are
revealing how post-transcriptional regulation introduces a
new layer of control that allows the cell to rapidly activate and
coordinate the expression of functionally related sets of genes
(for reviews, see Mata and coworkers [2] and Hieronymus
and Silver [3]). At the heart of these regulatory events is the
mRNP complex, a unique and dynamic combination of pro-
teins (and also small noncoding RNA molecules) that accom-
p a n i e s  e a c h  p a r t i c u l a r  m R N A  from the moment its first
nucleotides are synthesized. RNA-binding proteins (RBPs)
are the major determinants of the fate of an mRNA and so are
the main effectors of the post-transcriptional control of gene
expression. RBPs interact with mRNA through the recogni-
tion of sequence elements, and the distribution of distinct
consensus binding motifs in each mRNA species has been
proposed to constitute a combinatorial code that, by interfac-
ing with RBPs, will coordinate the destiny of groups of tran-
scripts in response to the cell's need [1,4]. This coordinated
regulation can be simultaneously imposed at different levels,
as a growing number of studies depict RBPs as multifunc-
tional proteins that can interface with the different cellular
machines that act upon mRNA [1].
The U2 small nuclear (sn)RNP auxiliary factor (U2AF) is a
highly conserved heterodimeric essential splicing factor,
composed of a 65 kDa and a 35 kDa subunit, with a well char-
acterized role during the early steps of spliceosome assembly
[5,6]. The large subunit of U2AF (U2AF65) has three RNA rec-
ognition motifs (RRMs) that determine its high affinity for
the intronic polypyrimidine tract upstream of the 3' splice site
[5], whereas the small subunit of U2AF (U2AF35) is responsi-
ble for the recognition of the conserved AG dinucleotide at the
3' splice site [7-9]. U2AF and the branch point binding pro-
tein SF1/mBBP [10] cooperatively establish a transient inter-
action with the pre-mRNA that is required for the
recruitment of the U2snRNP, leading to the subsequent
assembly of an active spliceosome complex.
Immunofluorescence microscopy reveals that, at steady state,
U2AF is detected exclusively in the cell nucleus [11]. However,
both subunits of the heterodimer shuttle continuously
between the nucleus and the cytoplasm [12], raising the pos-
sibility that U2AF may persist associated with mRNPs in
transit to the cytoplasm. Consistent with this view, U2AF was
implicated in mRNA export in both mammalian and Dro-
sophila systems [13,14]. To address the question of whether
U2AF65  associates with mature mRNAs, we performed a
genome-wide analysis of transcripts that were immunopre-
cipitated by a specific monoclonal antibody. For comparison
we analyzed mRNAs immunoprecipitated by an antibody
directed against the polypyrimidine tract binding protein
(PTB), one of the first well characterized paradigms of a mul-
tifunctional RBP [15]. PTB was originally identified as a com-
ponent of splicing complexes [16] and was later shown to be
an alternative splicing regulator. PTB binds to pyrimidine-
rich tracts on the precursor mRNA and, in general, functions
to repress the inclusion of alternative exons [17]. In addition
to its role in splicing, PTB has been shown to regulate 3' end
processing [18,19] and to be required for internal ribosome
entry site (IRES)-mediated translation of several viral and
cellular mRNAs [20]. PTB has also been implicated in the reg-
ulation of mRNA localization [21] and stability [22,23].
Using a combination of immunoprecipitation and microarray
analysis, we identify subsets of mRNAs that associate differ-
entially with U2AF65 and PTB, corresponding to approxi-
mately 10% of all cellular mRNAs expressed in HeLa cells. We
further demonstrate that U2AF65 binds either directly or indi-
rectly to defined spliced mRNA species, arguing that this
splicing protein most likely performs other functions in the
cell.
Results
U2AF65 is detected in cytoplasmic fractions in 
association with RNA
To investigate whether U2AF65 associates with mature mRNA
complexes, we separated HeLa cell lysates into nuclear and
postnuclear cytoplasmic fractions, as previously described
[24]. The resulting fractions were characterized by reverse
transcription (RT)-polymerase chain reaction (PCR; Figure
1a) and Western blotting (Figure 1b). As expected, the results
show that unspliced actin pre-mRNA is detected exclusively
in the nuclear fraction, whereas spliced mRNA is enriched in
the cytoplasmic fraction (Figure 1a). Moreover, well known
nuclear proteins such as hnRNP C and Sm are predominantly
detected in the nuclear fraction, whereas ribosomal protein
S6 is enriched in the cytoplasmic fraction (Figure 1b). Unex-
pectedly, a significant proportion of U2AF65 was present in
the cytoplasmic fraction, and a similar result was observed for
PTB (Figure 1b). Taking into account that immunofluores-
cence microscopy reveals that both U2AF65  and PTB are
highly concentrated in the nucleus, we consider it most likely
that the relatively large amounts of these proteins detected in
the cytoplasmic fraction reflect leakage of molecules that are
not tightly bound in the nucleus.
To determine whether U2AF65 and PTB molecules detected in
cytoplasmic fractions are associated with mRNPs, we frac-
tionated the extracts through Nycodenz gradients, which effi-
ciently separate mRNP complexes from free protein and
ribosomes [24]. Agarose gel electrophoresis of gradient sam-
ples shows that 28S and 18S rRNAs concentrate in fractions
10 to 12 (Figure 1c). Semi-quantitative RT-PCR reveals that
actin mRNA is preferentially detected in fractions 1, 2, 7, 8,
and 12 (Figure 1d). These results suggest that the Nycodenz
gradient resolves at least two distinct pools of mRNA: onehttp://genomebiology.com/2006/7/11/R113 Genome Biology 2006,     Volume 7, Issue 11, Article R113       Gama-Carvalho et al. R113.3
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Subcellular distribution of U2AF65 Figure 1
Subcellular distribution of U2AF65. (a) RT-PCR analysis of spliced and unspliced β-actin mRNA in cytoplasmic (Cyt) and nuclear (Nuc) fractions isolated 
from HeLa cells. Primer sequences on actin RNA and size of expected amplification products are depicted below the gel. (b) Western blot analysis of the 
cytoplasmic (Cyt) and nuclear (Nuc) fractions using antibodies against the indicated proteins. Molecular weight markers are shown on the left. Coomassie 
staining of the gel used for blotting confirms that both fractions contain similar amounts of total protein. (c) Agarose gel electrophoresis of total RNA 
extracted after Nycodenz gradient fractionation of cytoplasmic samples. rRNA bands are indicated on the right. Numbers indicate gradient fractions from 
low to high density. (d) Semiquantitative RT-PCR analysis of actin mRNA in the gradient fractions. (e) Western blot analysis of gradient fractions using 
anti-U2AF65 and anti-PTB antibodies. Molecular weight markers are indicated on the left. The 65 kDa band in the membrane after reprobing for PTB 
corresponds to residual signal from U2AF65 detection. (f) Western blot analysis of gradient fractions and input samples using anti-U2AF65 antibody. 
Extracts were either mock-treated (control) or incubated with RNase A before fractionation. Molecular weight markers are indicated on the left. Arrow 
points to the intermediate density fraction where U2AF65-containing complexes accumulate. PTB, polypyrimidine tract binding protein; RT-PCR, reverse 
transcription polymerase chain reaction; U2AF, U2 small nuclear RNP auxiliary factor.
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pool associates with ribosomes (corresponding to highest
density fractions) and the other consists of lower density
complexes devoid of ribosomes. Western blot analysis indi-
cates that both U2AF65 and PTB are enriched in lower density
fractions (Figure 1e), arguing that these proteins are not
major components of polysomes. Treatment of cell lysates
with RNase A before gradient fractionation resulted in a shift
of U2AF65 from intermediate density fractions (fractions 8
and 9) to less dense regions of the gradient (fractions 4 to 6;
Figure 1f), indicating that the presence of the protein in these
fractions is mediated by association with RNA. Taken
together, these results suggest that U2AF65 associates with
RNP complexes that are not tightly bound in the nucleus and
therefore are unlikely to contain pre-mRNA.
Microarray analysis identifies U2AF65-associated 
mRNAs
To further investigate whether U2AF65 associates with posts-
plicing mRNP complexes in the cell, we performed micro-
array analysis of mRNAs immunoprecipitated by an anti-
U2AF65 antibody. For comparison, we analyzed RNAs immu-
noprecipitated by an anti-PTB antibody. Three independent
immunoprecipitation experiments were performed for
U2AF65  and two independent immunoprecipitations were
performed for PTB. A mock RNA-immunoprecipitation assay
using empty beads was performed in parallel with each exper-
iment. Polyadenylated RNA from the input and immunopre-
cipitated samples was reverse transcribed, end-tagged, and
amplified by PCR within the linear range. The resulting
cDNAs were then labeled and hybridized to Affymetrix 133U
Plus 2.0 microarrays, which provide comprehensive coverage
of the whole transcribed human genome. No significant
amplification of cDNA was obtained in any of the mock
immunoprecipitations using beads devoid of antibody. From
each of the five precipitation experiments, we hybridized two
arrays, corresponding to the input RNA and the immunopre-
cipitated RNA.
Microarray hybridization data was analyzed using d-Chip
software [25]. To obtain an overview of RNA profiles from the
input and immunoprecipitation samples we first performed
an unsupervised clustering analysis on the complete dataset,
corresponding to ten microarray hybridization experiments.
Before clustering, a reduced list of transcripts with a viable
number of elements for analysis was generated by applying a
minimal filter, selecting for probes with an absolute differ-
ence in expression level between input samples and immuno-
precipitation samples of at least 100 (approximately 15,500
probes out of the 54,000 present in the array). Of these, 9781
were nonredundant probes, considered for clustering of both
samples and probes. The output tree produced by this analy-
sis is shown in Figure 2a. This unsupervised clustering of the
microarray dataset resulted in a clear separation of input and
immunoprecipitated samples, indicating that distinct subsets
of transcripts are enriched by the RNA immunoprecipitation,
depending on the target antigen. Figure 2b presents a super-
Clustering analysis of microarray data Figure 2
Clustering analysis of microarray data. (a) Unsupervised clustering of the 
microarray dataset was performed with the dChip software using standard 
settings considering all nonredundant probes with positive hybridization 
signal. The dataset includes microarray hybridization results from input 
and immunoprecipitation (IP) samples from three experiments with anti-
U2AF65 antibody (U1 to U3) and two experiments with anti-PTB antibody 
(P1 and P2). Sample clustering defines a tree with two first level branches 
corresponding to input and IP samples. (b) Re-clustering analysis after 
clearing transcripts that were over-represented either in the inputs or in 
all immunoprecipitation samples. Sample clustering defines a tree with 
three first level branches corresponding to input, U2AF65, and PTB 
immunoprecipitation samples. For clustering analysis, the probe signal 
intensities for each mRNA are standardized to have mean 0 and standard 
deviation 1 across all samples. The color scale for mRNAs is presented as 
follows: red represents expression level above mean expression of a gene 
across all samples, black represents mean expression; and green 
represents expression lower than the mean. Because of the 
standardization, probe signal intensities most likely fall within [-3, 3]. PTB, 
polypyrimidine tract binding protein; U2AF, U2 small nuclear RNP 
auxiliary factor.
(a) (b)
Input IP Input U2AF PTB
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vised clustering of this dataset, emphasizing the existence of
a population of transcripts that exhibit differential enrich-
ment in U2AF65 and PTB immunoprecipitation experiments.
To generate this cluster, the transcript list was further filtered
with standard dChip settings that select for probes that
exhibit wide variation across samples. Irrelevant probe clus-
ters present in the tree generated from this set of 1578 nonre-
dundant probes (clusters of probes enriched in all input or
immunoprecipitate samples or enriched in input and immu-
noprecipitate samples from the same experimental repli-
cates) were then manually cleared, followed by re-clustering
of the remaining probes. The tree generated by this approach
separates samples into three main branches, consistent with
their different origins, and highlights the existence of subsets
of transcripts that associate specifically with U2AF65 and PTB.
To identify the subset of cellular mRNA molecules that asso-
ciate with U2AF65 and PTB, we performed a comparison of
the microarray hybridization data from each pair of immuno-
precipitate and input samples (Additional data file 1). Using
this approach, we derived a list of probes that exhibit a signif-
icant increase in signal intensity in at least two replicate
immunoprecipitation  experiments (Additional data file 2).
The results obtained from this analysis indicate that both
U2AF65 and PTB associate with about 20% of the mRNAs
present in the input samples, and approximately half of the
transcripts enriched in the immunoprecipitates are common
to both proteins. Thus, mRNAs that associate specifically
with either U2AF65 or PTB correspond to about 10% of the
total expressed transcripts.
U2AF65 associates with spliced mRNAs
To validate the microarray data, we selected eight transcripts
found specifically enriched in the U2AF65 immunoprecipi-
tates and three transcripts not enriched in these samples;
similarly, we selected eight enriched and three nonenriched
transcripts in samples precipitated by the anti-PTB antibody.
The transcripts selected for analysis were chosen in order to
cover both high and low enrichment ratios and representative
functional categories (see below).
Three new independent immunoprecipitation  experiments
were performed using either anti-U2AF65 or anti-PTB anti-
bodies, and the levels of the precipitated mRNAs were ana-
lyzed by quantitative real-time PCR. Primers were designed
to span splice junctions, and agarose gel electrophoresis con-
firmed that amplified products from anti-U2AF65 immuno-
precipitations corresponded to spliced mRNA species (Figure
3a). Figure 3b depicts a comparison of microarray and quan-
titative real-time PCR data concerning enrichment of the
selected mRNAs in the immunoprecipitated samples. As
shown in the figure, the two kinds of data provide the same
trends, thus confirming the associations detected by the array
experiments.
To confirm that the U2AF65  associated mRNAs are fully
spliced, we performed a RT-PCR amplification from the first
to last exon for targets with an appropriate size range (Figure
4). As shown in Figure 4, fully spliced mRNAs are detectable
in the U2AF65  immunoprecipitates for all the transcripts
tested, thus demonstrating the association of U2AF65 with
mature mRNA. Transcripts encoded by intronless genes are
also found in the anti-U2AF65 immunoprecipitates (Figure 4),
suggesting that the association between this protein and
mRNA is not splicing dependent.
mRNAs that associate preferentially with either 
U2AF65 or PTB belong to different gene ontology 
groups and have distinct sequence characteristics
To identify the functions of cellular mRNAs that were
enriched in the U2AF65 and PTB immunoprecipitated frac-
tions, the probes listed in Additional data file 2 were analyzed
using d-Chip software [25] and the DAVID functional annota-
tion tool [26]. The results from Gene Ontology classification
reveal a statistically significant bias in the distribution of the
products encoded by these mRNAs into different functional
categories, when compared with their relative frequency in
the genome (Tables 1 and 2). This bias was not observed when
analyzing a random list of equivalent size generated from the
population of expressed microarray probes. The U2AF65-
associated mRNA population is highly enriched in mRNAs
encoding transcription and cell cycle regulators, whereas
PTB-associated mRNAs contain a large proportion of tran-
scripts encoding proteins that are involved in intracellular
transport and vesicle trafficking. An additional group of genes
related to ubiquitination and signaling through small GTPase
molecules exhibits significant enrichment in both U2AF65-
and PTB-associated mRNA populations. Thus, using two
independent software tools to perform the annotation of the
mRNAs bound by U2AF65  and PTB, we have obtained
evidence for a distinctive functional profile underlying the
two populations identified in the microarray analysis.
Next, we performed a systematic sequence analysis for the
presence of U2AF65 and PTB consensus binding motifs in the
mRNA populations found to be associated preferentially with
each of these two proteins. The motifs used for searching the
mRNA sequences have previously been described in the
literature [7,27] (Additional data file 3). For comparison pur-
poses, we defined for both U2AF65 and PTB a control popula-
tion of nonassociated transcripts composed of all microarray
probes with a negative fold change value in at least two repli-
cate immunoprecipitation experiments (Additional data file
2). To search for the consensus motifs, a Perl script was
designed to retrieve the sequence of the longest curated tran-
script available in the major nucleotide databases that corre-
sponds to the reference sequence for the Affymetrix
microarray probe sets belonging to the different transcript
subsets (listed in Additional data file 2). We retrieved
sequence information for approximately 80% of the tran-
scripts in the original datasets, as listed in Additional data fileR113.6 Genome Biology 2006,     Volume 7, Issue 11, Article R113       Gama-Carvalho et al. http://genomebiology.com/2006/7/11/R113
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Validation of the mRNA-protein associations identified by microarray analysis Figure 3
Validation of the mRNA-protein associations identified by microarray analysis. (a) RT-PCR amplification of putative U2AF65 associated mRNAs and a 
nonassociated mRNA (glucose-6-phosphate dehydrogenase [G6PD]) from immunoprecipitation (RIP), mock-imunoprecipitation (Mock), and input 
samples. For each target, the primer localization and expected size of amplified spliced products is indicated. (b) Comparison of microarray quantification 
and independent real time-PCR quantification of the enrichment index (log2 immunoprecipitation/input) of selected target mRNAs from anti-U2AF65 or 
anti-PTB immunoprecipitation experiments. Points falling in the positive (+/+) or negative (-/-) sectors of the plot reveal an agreement between microarray 
and quantitative real-time PCR experiments. The SMARCA2 and MAPK8 mRNA were found to be enriched only in microarray experiments. IP, 
immunoprecipitation; PTB, polypyrimidine tract binding protein; RT-PCR, reverse transcription polymerase chain reaction; U2AF, U2 small nuclear RNP 
auxiliary factor.
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U2AF65 associates with fully spliced mRNAs Figure 4
U2AF65 associates with fully spliced mRNAs. Agarose gel electrophoresis of RT-PCR reactions designed to check the splicing status of mRNAs present in 
control (Mock) and anti-U2AF65 (U2AF) RNA-immunoprecipitations. For each target, the transcript exon/intron structure is represented to scale and 
primer localization and expected size of fully spliced products are indicated. IP, immunoprecipitation; RT-PCR, reverse transcription polymerase chain 
reaction; U2AF, U2 small nuclear RNP auxiliary factor.
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4. Because differences in the number of identified consensus
motifs will reflect differences in transcript size, the compari-
son between protein-associated and control mRNA popula-
tions was performed after calculating the density of
consensus binding motifs for each transcript (number of hits/
nucleotide).
Interestingly, we find that the average size of transcripts in
the U2AF65- and PTB-associated samples differs from control
populations and the variation is mainly due to differences in
the average size of the 3'-untranslated region (UTR; Figure
5a). The average 3'-UTR size of the control (nonassociated)
population is 60% smaller than the corresponding value for
the U2AF65- or PTB-associated populations. Comparison
between the U2AF65- and PTB-associated mRNAs and the
respective control nonassociated mRNA population reveals
1.4-fold and 1.5-fold differences in the average density of
putative binding sites for these proteins per transcript (Figure
5b). Moreover, comparative analysis of the distribution of
putative binding sites in the coding and noncoding regions of
the transcripts reveals a statistically significant enrichment in
consensus motif density in the coding region and 3'-UTR,
contrasting with the 5'-UTR (Figure 5c). These results impli-
cate the coding region and 3'-UTRs in U2AF65- and PTB-asso-
ciated mRNAs as potential targets for the direct binding of
U2AF65 and PTB.
Discussion
Currently available data suggest that a multifunctional nature
is more likely to be the rule than the exception among RBPs
[1]. Dissecting the cellular roles of multifunctional regulators
of gene expression through classical approaches involving
knock-down or over-expression is not an easy task, because
the inhibition of upstream functions such as transcription
and splicing will obscure downstream effects on export, sta-
bility, translation, or localization. We therefore decided to
take a different approach, beginning with the identification of
U2AF65-mRNA targets as a starting point to search for poten-
tial novel functions of U2AF65. Putative U2AF65 mRNA tar-
gets identified through the microarray analysis of RNA-
immunoprecipitations performed with a monoclonal anti-
body specific for this protein were confirmed by independent
RT-PCR analysis, arguing for the specificity of the results
obtained. However, as an additional methodological control
for the reliability of this type of large scale approach, we per-
formed a parallel analysis for PTB.
PTB was selected for two main reasons. First, PTB and
U2AF65 have relatively similar RNA-binding preferences for
pyrimidine-rich stretches, which is underscored by the fact
that they can compete for binding to the same intronic
sequence elements in alternative splicing regulation [27].
However, in spite of this similarity, we found the mRNA-
binding profiles of these two proteins to be quite different.
Second, PTB is a well characterized multifunctional RBP that
has post-splicing functions on known mRNA targets. Impor-
tantly, most of these have been identified as associating with
this protein in our large-scale screen.
PTB was implicated in the stabilization of mRNAs encoding
secretory granule proteins both in pancreatic islet cells pro-
moting insulin secretion in response to glucose stimulation
[22] and during T-lymphocyte activation [28]. Among the
PTB targets described in those studies, only two (synaptobre-
vin 1 and 2) are expressed in HeLa cells, and both were iden-
tified as PTB-associated in our screen. A role for PTB as an
internal ribosome entry segment (IRES) trans-acting factor
Table 1
Summary of dChip Gene Ontology classification of target mRNA populations
Cellular function Gene Ontology group U2AF (%) PTB (%) Array (%)
Gene expression DNA binding 20.7 - 13.7
Transcription 16.9 - 11.9
Transcription regulator 13.5 - 8.5
Transcription factor 9.9 - 6.3
RNA binding 5.2 - 3.6
Cell cycle Cell cycle 6.7 - 4.6
Regulation of cell cycle 4.1 - 2.7
Ubiquitination Ubiquitin conjugating enzyme activity 1.6 1.7 0.5
Signaling Small GTPase mediated signal transduction 2.7 3.5 1.5
Intracellular transport and vesicles Intracellular protein transport - 5.6 2.5
Vesicle-mediated transport - 3.9 2.1
Golgi apparatus - 3.6 1.9
Golgi trans face - 0.5 0.1
In the U2AF and PTB columns, '-' indicates that enrichment was not significant relative to the proportion of array genes belonging to the Gene 
Ontology group (P > 0.001). PTB, polypyrimidine tract binding protein; U2AF, U2 small nuclear RNP auxiliary factor.http://genomebiology.com/2006/7/11/R113 Genome Biology 2006,     Volume 7, Issue 11, Article R113       Gama-Carvalho et al. R113.9
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has also been demonstrated for seven cellular mRNAs [29].
Six of the seven reported mRNAs showed detectable expres-
sion levels in our assay. From these, three (Apaf-1, Bag-1, and
Myb) were identified as PTB-associated in our screen and
another two (IGF1R and Mnt) were positively enriched in the
immunoprecipitated samples but were just below the estab-
lished cut-off values in one of the experiments. It is notewor-
thy that Apaf-1 and Bag-1 proteins are essential for the
apoptotic process (for review, see Spriggs and coworkers
[29]). Thus, in addition to having identified previously
described PTB mRNA targets, our analysis reveals many
novel putative PTB-associated mRNAs that are involved in
the same cellular pathways previously associated with this
protein (intracellular transport, vesicle trafficking, and
apoptosis). The consistency of the results obtained in the
analysis of the anti-PTB RNA-immunoprecipitation experi-
ments strongly supports our interpretation of the data
obtained for U2AF65.
Our results reveal that, in addition to binding to intronic
sequence elements in the pre-mRNA during the first steps of
spliceosome assembly, U2AF65 also associates with a subset of
spliced cellular mRNAs. Functional annotation of the mRNAs
that associate specifically with U2AF65  shows significant
enrichment in molecules encoding transcription, chromatin,
and cell cycle regulators, in particular those involved in the
G1/S transition. According to the post-transcriptional operon
model [4], this bias suggests that the expression of a subset of
genes involved in cell cycle progression and in the regulation
of specific gene expression programs could be coordinated at
the post-transcriptional level by U2AF65. Interestingly, a
function in cell cycle progression and maintenance of chro-
matin and nuclear structure has previously been proposed for
the Schizosaccharomyces pombe homolog of the U2AF large
subunit [30]. Based on our findings, we suggest that U2AF65
should be viewed as a multifunctional protein and propose
the existence of novel functions for this protein in mRNA
metabolism. A precedent for this was established in a recent
analysis of a temperature-sensitive RNA binding mutant of
the yeast U2AF65 homolog in transgenic Drosophila [14], in
which this protein was shown to be required for the export of
several intronless mRNAs, by directly binding to the message.
However, analysis of the U2AF65-associated mRNA popula-
tion that we report in this work did not reveal any bias toward
intronless gene transcripts when compared with randomly
selected populations mRNA populations (data not shown).
Involvement of shuttling splicing factors in several distinct
postsplicing activities has already been reported for members
of the U2AF-related SR protein family, which have been
Table 2
Summary of DAVID Gene Ontology classification of target mRNA populations
Cellular function Gene Ontology group U2AF (%) PTB (%)
Gene expression Transcription, DNA-dependent 13.1 10.6
Transcription from Pol II promoter 3.8 3.1
Negative regulation of transcription from Pol II promoter 0.7 -
DNA packaging 1.4 -
Nuclear mRNA splicing, via spliceosome 1.2 -
Translation 1.1 -
Cell cycle Cell proliferation 6.5 5.6
Cell cycle 4.9 4.1
Regulation of cell cycle 3 2.3
G1/S transition of mitotic cell cycle 0.6 -
Mitotic cell cycle 1.3 -
Apoptosis Death - 3
Apoptosis - 2.8
Negative regulation of apoptosis 0.9
Ubiquitination Ubiquitin cycle 4.9 4.5
Protein ubiquitination 2.6 2.1
Signaling Intracellular signaling cascade 6 6.8
Small GTPase mediated signal transduction 1.9 2.6
Intracellular transport and vesicles Establishment of localization - 10.4
Endosome organization and biogenesis - 0.4
Endosome transport - 0.3
Vesicle-mediated transport - 2.1
In the U2AF and PTB columns, '-' indicates that enrichment was not significant relative to the proportion of array genes belonging to the Gene 
Ontology group (P > 0.001). PTB, polypyrimidine tract binding protein; U2AF, U2 small nuclear RNP auxiliary factor.R113.10 Genome Biology 2006,     Volume 7, Issue 11, Article R113       Gama-Carvalho et al. http://genomebiology.com/2006/7/11/R113
Genome Biology 2006, 7:R113
shown to participate in mRNA export, translation, and stabil-
ity [31-33]. Future studies will clarify whether the U2AF65-
mRNP complexes identified in this work correspond predom-
inantly to nuclear mRNPs in transit to the cytoplasm or
whether this protein is also involved in the cytoplasmic
metabolism of mRNAs.
Conclusion
The microarray analysis of α-PTB and α-U2AF65 RNA immu-
noprecipitations reveals that these splicing factors can associ-
ate with a large subset of spliced cellular mRNAs. The mRNA
populations associated with each protein contain distinctive
sequence features, which are predicted to mediate direct
protein-RNA interactions. Additionally, the products
encoded by each mRNA population exhibit differential
enrichment in proteins that are functionally related. This sup-
ports the existence of post-transcriptional regulatory net-
works involving the specific binding of U2AF65 and PTB to
two distinct groups of functionally related mRNAs, similar to
what has been recently proposed for other RNA binding pro-
teins [34-36]. Furthermore, our data provide the first clues to
novel roles of human U2AF65 in the postsplicing regulation of
mRNAs important for transcriptional control and the cell
cycle.
Materials and methods
Cell culture and extracts
For isolation of mRNP complexes, suspension HeLa cells
were grown in Dulbecco's modified Eagle's medium (DMEM),
10% fetal calf serum (FCS) and penicillin/streptomycin, and
split 1:2 the day before harvesting. For all other experiments,
adherent HeLa cells (ECACC 93021013) were grown in mini-
mum essential medium (MEM), 10% FCS, and nonessential
aminoacids at 37°C. Postnuclear cytoplasmic extracts were
obtained as described previously [24], using 5 × 107 cells/ml
lysis buffer. For Western blotting analysis, 2.5 μl of extract
was run in a 12% SDS-PAGE gel. The pellet fraction was re-
suspended in SDS-PAGE buffer and an equivalent volume
was analyzed. For RNAse treatment, samples were incubated
with 200 μg RNAse A for 15 min at 37°C before gradient
fractionation.
Antibodies
The following antibodies were used for immunoprecipitation
or Western blotting: anti-U2AF65 MC3 monoclonal antibody
[11], anti-PTB Bb7 monoclonal antibody (American Type Cul-
ture Collection, Manassas, VA, USA), anti-Sm Y12 mono-
clonal antibody [37], anti-hnRNPC1/C2 mAb 4F4 [38], and
anti-S6 rabbit polyclonal serum (Cell Signaling Technology
Inc, Danvers, MA, USA).
Isolation of mRNP complexes
mRNP complex isolation by gradient fractionation through a
20% to 60% Nycodenz gradient (Accurate Chemical and Sci-
entific Corp., Westbury, NY, USA) was performed as
described previously [24]. After centrifugation, 0.5 ml frac-
tions were collected by underlaying with a 65% Nycodenz
solution using an automatic fractionator (Bio-Rad Laborato-
ries, Hercules, CA, USA). Gradient fractions were TCA precip-
itated, and one-third of the final volume was used for Western
blotting analysis. For RNA isolation, fractions were diluted
with 250 μl of water and extracted with acid phenol, followed
either by denaturing agarose gel analysis or reverse transcrip-
tion and PCR amplification as described below.
RNA immunoprecipitation
Isolation of U2AF65- or PTB-associated mRNAs under native
conditions was performed by immunoprecipitation from 200
μl of precleared HeLa cell lysate, using the anti-U2AF65 MC3
monoclonal antibody (mAb) or the Bb7 anti-PTB mAb for 2
hours at 4°C. Antibody concentrations were adjusted empiri-
cally. Immune complexes were precipitated with a slurry with
50% of protein A/protein G agarose beads (GE Healthcare UK
Ltd (formerly Amersham Biosciences Corp.), Little Chalfont,
Buckinghamshire, England) and blocked with 100 μg/μl of
tRNA and RNAse free bovine serum albumin (Ambion, Inc.,
Austin, USA) by rotating for 1 hour at 4°C. Washes were per-
formed with lysis buffer. Complexes bound to the beads were
eluted with TES buffer (10 mmol/l Tris, 0.5 mol/l EDTA,
0.5% SDS [pH 8.0]) by heating at 65°C for 10 minutes. A 15 μl
Size analysis of coding sequence and UTRs of U2AF65- and PTB-associated mRNA populations Figure 5 (see following page)
Size analysis of coding sequence and UTRs of U2AF65- and PTB-associated mRNA populations. (a) Average size of 5' and 3' UTRs and coding sequence 
(CDS) for mRNAs in the U2AF65-associated or PTB-associated populations and their respective control (nonassociated) populations (Additional data file 
2). For this analysis, information for the longest curated transcript available in EMBL [40], GenBank [41], and RefSeq [42] databases was retrieved for all 
entries in each population, when available (Additional data file 4). Statistically significant differences between the associated and the respective control 
populations are indicated. (b) Analysis of putative U2AF65 and PTB binding motifs in selected mRNA populations. The longest curated transcripts for 
mRNA accessions in the U2AF65-associated or PTB-associated populations and their respective control (nonassociated) populations were searched for 
putative U2AF65- and PTB-binding motifs. Graphs present average U2AF65 motif density in the U2AF65-associated and control populations, and average 
PTB motif density in the PTB-associated and control populations. The ratio between values for each associated/control pair is shown. (c) Analysis of the 
distribution of putative U2AF65- and PTB-binding motifs in the different transcript regions. Graphs present average U2AF65 motif density by transcript 
region in the U2AF65-associated and control populations and average PTB motif density by transcript region in the PTB-associated and control populations. 
The ratio between values for each associated/control pair is shown. *P << 0.001. n, population size; n.s., not significant; PTB, polypyrimidine tract binding 
protein; U2AF, U2 small nuclear RNP auxiliary factor; UTR, untranslated region.http://genomebiology.com/2006/7/11/R113 Genome Biology 2006,     Volume 7, Issue 11, Article R113       Gama-Carvalho et al. R113.11
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Figure 5 (see legend on previous page)
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sample of the eluted complexes was used for Western blotting
to confirm the efficiency of immunoprecipitation and the rest
was Trizol extracted for mRNA analysis.
Oligonucleotide array expression analysis of U2AF65- 
and PTB-associated mRNAs
Polyadenilated RNAs obtained by anti-U2AF65 and anti-PTB
immunoprecipitation were reverse transcribed and PCR
amplified using the Super SMART PCR cDNA synthesis kit
from Clontech (Clontech Laboratories, Inc., Mountain View,
CA, USA), following the manufacturer's instructions. One
microgram of input or precipitated RNA or an equivalent
sample volume from mock pull-down assays was used was
used per RT-PCR reaction to produce samples for microarray
hybridization. For each set of samples (input, pull-down, and
mock pull-down), a 100 μl test PCR reaction was performed
in accordance with the manufacturer's instructions and ana-
lyzed by agarose gel electrophoresis to select ideal conditions
for amplification in the linear range. For microarray hybridi-
zation, 15 μg of PCR amplified cDNA from input and immu-
noprecipitated samples were prepared and hybridized to
Affymetrix GeneChip Human Genome U133 Plus 2.0 Arrays
(Affymetric, Inc., Santa Clara, CA, USA), as described else-
where [39]. Microarray data have been deposited in the GEO
database and are available through the series accession num-
bers GSE6021 (PTB immunoprecipitation data) and
GSE6022 (U2AF immunoprecipitation data).
Analysis of microarray results was performed with dChip
[25]. To identify mRNAs enriched by the immunoprecipita-
tion procedure, a comparison analysis was performed
between each experimental pair dataset (input and immuno-
precipitation samples) with output of all genes. Fold change
cutoff criteria was established by determining the 95th per-
centile of the frequency distribution MBEI (model based
expression index) increment introduced by experimentally
measured standard errors (SE) for all P probes in each exper-
imental dataset pair. Comparison results were combined to
identify probe sets satisfying the cutoff criteria (specifically,
fold change above the determined cutoff value [using the 90%
lower boundary interval] and difference in MBEI > 100) in at
least two experiments.
cDNA synthesis, RT-PCR, and quantitative real-time 
PCR
cDNA was synthesized from 500 ng purified RNA or one-
quarter of Nycodenz gradient fractions using oligo-dT prim-
ers and the Superscript II Reverse Transcriptase (Invitrogen
Corporation, Carlsbad, CA, USA), as recommended by the
manufacturer. PCR amplification was performed using the
Bio-X-Act DNA polymerase (Bioline Ltd, London, UK), as
recommended by the manufacturer, using the following con-
ditions: 2 minutes at 95°C and 20 to 30 cycles at 95°C for 1
minute, at 55°C for 1 minute, and at 72°C for 1 minute. Primer
sequences were as indicated in Additional data file 5. Quanti-
fication of ethidium bromide signal from agarose gels was
performed on a Typhoon Laser Scanner using the Image-
Quant 5.2 software (GE Healthcare UK Ltd, Little Chalfont,
Buckinghamshire, England). Real-time quantitative PCR was
performed on an ABI PRISM 7000 Sequence Detection Sys-
tem (Applied Biosystems, Foster City, CA, USA) using the
SYBR Green PCR master mix (Applied Biosystems, Foster
City, CA, USA). Quantification of results was performed with
the AbiPrism 7000 SDS software (Applied Biosystems, Foster
City, CA, USA). For the quantitative analysis of RNA immu-
noprecipitations, a standard curve obtained from serial dilu-
tions of Hela cDNA was used to determine the relative
amount of specific target RNAs from the different samples.
Sequence analysis
A Perl script was written to annotate the mRNA sequences
and search them for binding motifs. Each mRNA accession
number from the Affimetrix array was used to search Uni-
Gene (version 176) [14] for a corresponding gene identifier.
For each gene, the longest curated transcript available in
EMBL [40], GenBank [41] and RefSeq [42] databases was
retrieved using Bioperl (version 1.4) modules [43]. For each
of these transcripts, the annotation of coding sequence and
UTRs was also performed. The transcript sequences were
then searched for putative binding motifs for PTB and U2AF
using scoring matrices. The sequence YYYYTCTTYYYY was
searched for as a putative motif for PTB [44,45], using a scor-
ing matrix (see Additional data file 3). For U2AF a frequency
matrix was derived, based on sequences from a SELEX exper-
iment described by Wu and coworkers [46] (Additional data
file 3). In all cases, the selected cut-off scores for a positive hit
are the highest possible values that produce a Gaussian distri-
bution of the frequency of motifs found in the full-length
mRNA.
Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 is a figure present-
ing detailed results regarding the initial steps in the micro-
array data analysis. Additional data file 2 includes tables that
contain lists of mRNAs associated with U2AF65 and PTB and
control nonassociated mRNA populations. Additional data
file 3 is a document detailing the methods used for sequence
analysis of consensus binding motifs. Additional data file 4
includes lists of the subsets of mRNAs that were subject to
sequence analysis of consensus binding motifs and details the
results of this analysis. Additional data file 5 is a document
containing the primer sequences used.
Additional data file 1 Figure presenting detailed results regarding the initial steps in the  microarray data analysis Figure presenting detailed results regarding the initial steps in the  microarray data analysis. Click here for file Additional data file 2 Lists of mRNAs associated with U2AF65 and PTB and control non- associated mRNA populations Lists of mRNAs associated with U2AF65 and PTB and control non- associated mRNA populations. Click here for file Additional data file 3 Methods used for sequence analysis of consensus binding motifs Methods used for sequence analysis of consensus binding motifs. Click here for file Additional data file 4 Lists of the subsets of mRNAs that were subject to sequence analy- sis of consensus binding motifs and the results of this analysis Lists of the subsets of mRNAs that were subject to sequence analy- sis of consensus binding motifs and the results of this analysis. Click here for file Additional data file 5 Primer sequences used Primer sequences used. Click here for file
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